Every year, over 3,00,000 infants are born with Sickle Cell Disease (SCD) worldwide ... to Action”, led by Hindustantimes.com and HealthShots in partnership with Novo Nordisk India. Flagged off on ...

How does Innovent Biologics' mazdutide, a groundbreaking dual GLP-1/glucagon receptor drug just approved in China, compared to Wegovy and Zepbound? Read more here.

Brandon Kistler, PhD, RD, took a kidney disease dietetic internship in college that changed the course of his career. He ...

The Food and Drug Administration has approved Harliku (nitisinone) for the reduction of urine homogentisic acid in adult patients with alkaptonuria.